Literature DB >> 10364516

X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene.

S W Knight1, N S Heiss, T J Vulliamy, S Greschner, G Stavrides, G S Pai, G Lestringant, N Varma, P J Mason, I Dokal, A Poustka.   

Abstract

Dyskeratosis congenita is a rare inherited bone marrow-failure syndrome characterized by abnormal skin pigmentation, nail dystrophy, and mucosal leukoplakia. More than 80% of patients develop bone-marrow failure, and this is the major cause of premature death. The X-linked form of the disease (MIM 305000) has been shown to be caused by mutations in the DKC1 gene. The gene encodes a 514-amino-acid protein, dyskerin, that is homologous to Saccharomyces cerevisiae Cbf5p and rat Nap57 proteins. By analogy to the homologues in other species, dyskerin is predicted to be a nucleolar protein with a role in both the biogenesis of ribosomes and, in particular, the pseudouridylation of rRNA precursors. We have determined the genomic structure of the DKC1 gene; it consists of 15 exons spanning a region of 15 kb. This has enabled us to screen for mutations in the genomic DNA, by using SSCP analysis. Mutations were detected in 21 of 37 additional families with dyskeratosis congenita that were analyzed. These mutations consisted of 11 different single-nucleotide substitutions, which resulted in 10 missense mutations and 1 putative splicing mutation within an intron. The missense change A353V was observed in 10 different families and was shown to be a recurring de novo event. Two polymorphisms were also detected, one of which resulted in the insertion of an additional lysine in the carboxy-terminal polylysine domain. It is apparent that X-linked dyskeratosis congenita is predominantly caused by missense mutations; the precise effect on the function of dyskerin remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364516      PMCID: PMC1378074          DOI: 10.1086/302446

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  38 in total

1.  Rapid PCR analysis of the St14 (DXS52) VNTR.

Authors:  B Richards; R Heilig; I Oberlé; L Storjohann; G T Horn
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

2.  A novel human nonviral retroposon derived from an endogenous retrovirus.

Authors:  M Ono; M Kawakami; T Takezawa
Journal:  Nucleic Acids Res       Date:  1987-11-11       Impact factor: 16.971

3.  A catalogue of splice junction sequences.

Authors:  S M Mount
Journal:  Nucleic Acids Res       Date:  1982-01-22       Impact factor: 16.971

4.  Assignment of the gene for dyskeratosis congenita to Xq28.

Authors:  J M Connor; D Gatherer; F C Gray; L A Pirrit; N A Affara
Journal:  Hum Genet       Date:  1986-04       Impact factor: 4.132

5.  Molecular characterization of beta-thalassemia intermedia in patients of Italian descent and identification of three novel beta-thalassemia mutations.

Authors:  S Murru; G Loudianos; M Deiana; C Camaschella; G V Sciarratta; S Agosti; M I Parodi; P Cerruti; A Cao; M Pirastu
Journal:  Blood       Date:  1991-03-15       Impact factor: 22.113

6.  Cytogenetic studies of skin fibroblast cultures from a karyotypically normal female with dyskeratosis congenita.

Authors:  H Kehrer; W Krone; D Schindler; R Kaufmann; H Schrezenmeier
Journal:  Clin Genet       Date:  1992-03       Impact factor: 4.438

7.  Nopp140 shuttles on tracks between nucleolus and cytoplasm.

Authors:  U T Meier; G Blobel
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

8.  Bleomycin hypersensitivity in dyskeratosis congenita fibroblasts, lymphocytes, and transformed lymphoblasts.

Authors:  G S Pai; Y Yan; D M DeBauche; W S Stanley; S R Paul
Journal:  Cytogenet Cell Genet       Date:  1989

9.  A novel beta thalassemia gene with a single base mutation in the conserved polypyrimidine sequence at the 3' end of IVS 2.

Authors:  C Beldjord; C Lapoumeroulie; J Pagnier; M Benabadji; R Krishnamoorthy; D Labie; A Bank
Journal:  Nucleic Acids Res       Date:  1988-06-10       Impact factor: 16.971

10.  A variable number of tandem repeats locus within the human complement C2 gene is associated with a retroposon derived from a human endogenous retrovirus.

Authors:  Z B Zhu; S L Hsieh; D R Bentley; R D Campbell; J E Volanakis
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

View more
  85 in total

1.  Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita.

Authors:  Cristian Bellodi; Noam Kopmar; Davide Ruggero
Journal:  EMBO J       Date:  2010-05-07       Impact factor: 11.598

2.  Connecting complex disorders through biology.

Authors:  Sharon A Savage
Journal:  Nat Genet       Date:  2012-02-27       Impact factor: 38.330

Review 3.  The molecular genetics of the telomere biology disorders.

Authors:  Alison A Bertuch
Journal:  RNA Biol       Date:  2015-09-23       Impact factor: 4.652

4.  Synonymous Mutation in DKC1 Causes Telomerase RNA Insufficiency Manifesting as Familial Pulmonary Fibrosis.

Authors:  Valeriya Gaysinskaya; Susan E Stanley; Soheir Adam; Mary Armanios
Journal:  Chest       Date:  2020-07-22       Impact factor: 9.410

Review 5.  The genetics of dyskeratosis congenita.

Authors:  Philip J Mason; Monica Bessler
Journal:  Cancer Genet       Date:  2011-12

6.  Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells.

Authors:  Rodrigo T Calado; William T Yewdell; Keisha L Wilkerson; Joshua A Regal; Sachiko Kajigaya; Constantine A Stratakis; Neal S Young
Journal:  Blood       Date:  2009-06-26       Impact factor: 22.113

Review 7.  Dyskeratosis congenita: a disorder of defective telomere maintenance?

Authors:  Amanda J Walne; Anna Marrone; Inderjeet Dokal
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

8.  Investigation of chromosome X inactivation and clinical phenotypes in female carriers of DKC1 mutations.

Authors:  Jialin Xu; Payal P Khincha; Neelam Giri; Blanche P Alter; Sharon A Savage; Judy M Y Wong
Journal:  Am J Hematol       Date:  2016-11-04       Impact factor: 10.047

Review 9.  Non-coding RNAs and disease: the classical ncRNAs make a comeback.

Authors:  Rogerio Alves de Almeida; Marcin G Fraczek; Steven Parker; Daniela Delneri; Raymond T O'Keefe
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

10.  The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor.

Authors:  Benigno C Valdez; Dale Henning; Rolando B So; Jill Dixon; Michael J Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.